Great Point Partners, LLC 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:47 pm Sale | 2024-09-30 | 13G | UroGen Pharma Ltd. URGN | Great Point Partners, LLC | 758,786 1.800% | -1,861,759 (-71.04%) | Filing |
| 2024-02-14 4:38 pm Unchanged | 2023-12-31 | 13G | UroGen Pharma Ltd. URGN | Great Point Partners, LLC | 2,620,545 8.490% | 0 (Unchanged) | Filing |
| 2023-09-15 1:39 pm Purchase | 2023-09-08 | 13G | UroGen Pharma Ltd. URGN | Great Point Partners, LLC | 2,620,545 8.510% | 2,620,545 (New Position) | Filing |